Clinical Trial

A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS

Name: A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS — clinical trial record (NCT07169175)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to evaluate the safety, tolerability and preliminary efficacy of SNUG01 in in adult subjects with Amyotrophic Lateral Sclerosis (ALS).

Trial Details

NCT Number	NCT07169175
Lead Sponsor	SineuGene Therapeutics Co., Ltd.
Conditions	Amyotrophic Lateral Sclerosis (ALS)
Enrollment	21 participants
Start Date	2025-12-01
Primary Completion	2028-03-30 (estimated)
Study Completion	2028-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-11